|
Gene: CRIP1 |
Gene summary for CRIP1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | CRIP1 | Gene ID | 1396 |
Gene name | cysteine rich protein 1 | |
Gene Alias | CRHP | |
Cytomap | 14q32.33 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P50238 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1396 | CRIP1 | GSM4909287 | Human | Breast | IDC | 1.96e-07 | 3.17e-01 | 0.2057 |
1396 | CRIP1 | GSM4909289 | Human | Breast | IDC | 4.59e-13 | 8.46e-01 | 0.1064 |
1396 | CRIP1 | GSM4909290 | Human | Breast | IDC | 1.24e-95 | 1.65e+00 | 0.2096 |
1396 | CRIP1 | GSM4909293 | Human | Breast | IDC | 8.65e-42 | 7.39e-01 | 0.1581 |
1396 | CRIP1 | GSM4909294 | Human | Breast | IDC | 2.97e-21 | 7.03e-01 | 0.2022 |
1396 | CRIP1 | GSM4909295 | Human | Breast | IDC | 2.87e-07 | 4.80e-01 | 0.0898 |
1396 | CRIP1 | GSM4909296 | Human | Breast | IDC | 2.46e-106 | 1.73e+00 | 0.1524 |
1396 | CRIP1 | GSM4909297 | Human | Breast | IDC | 7.02e-07 | 4.21e-01 | 0.1517 |
1396 | CRIP1 | GSM4909301 | Human | Breast | IDC | 3.22e-136 | 1.75e+00 | 0.1577 |
1396 | CRIP1 | GSM4909302 | Human | Breast | IDC | 5.62e-53 | 1.09e+00 | 0.1545 |
1396 | CRIP1 | GSM4909303 | Human | Breast | IDC | 1.66e-05 | 5.34e-01 | 0.0438 |
1396 | CRIP1 | GSM4909304 | Human | Breast | IDC | 4.37e-102 | 1.32e+00 | 0.1636 |
1396 | CRIP1 | GSM4909305 | Human | Breast | IDC | 5.81e-15 | 4.88e-01 | 0.0436 |
1396 | CRIP1 | GSM4909306 | Human | Breast | IDC | 2.60e-52 | 1.02e+00 | 0.1564 |
1396 | CRIP1 | GSM4909307 | Human | Breast | IDC | 6.43e-20 | 5.89e-01 | 0.1569 |
1396 | CRIP1 | GSM4909308 | Human | Breast | IDC | 3.87e-02 | 1.36e-01 | 0.158 |
1396 | CRIP1 | GSM4909309 | Human | Breast | IDC | 1.44e-16 | 7.14e-01 | 0.0483 |
1396 | CRIP1 | GSM4909311 | Human | Breast | IDC | 2.56e-44 | 1.14e+00 | 0.1534 |
1396 | CRIP1 | GSM4909312 | Human | Breast | IDC | 5.70e-52 | 1.16e+00 | 0.1552 |
1396 | CRIP1 | GSM4909313 | Human | Breast | IDC | 9.10e-42 | 1.23e+00 | 0.0391 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00308507 | Skin | AK | prostate gland development | 14/1910 | 45/18723 | 9.94e-05 | 1.32e-03 | 14 |
GO:000165510 | Skin | AK | urogenital system development | 54/1910 | 338/18723 | 5.86e-04 | 5.20e-03 | 54 |
GO:00346446 | Skin | AK | cellular response to UV | 20/1910 | 90/18723 | 6.22e-04 | 5.45e-03 | 20 |
GO:00094116 | Skin | AK | response to UV | 28/1910 | 149/18723 | 1.05e-03 | 8.24e-03 | 28 |
GO:001003828 | Skin | AK | response to metal ion | 57/1910 | 373/18723 | 1.26e-03 | 9.52e-03 | 57 |
GO:00614483 | Skin | AK | connective tissue development | 40/1910 | 252/18723 | 3.17e-03 | 1.95e-02 | 40 |
GO:00094166 | Skin | AK | response to light stimulus | 48/1910 | 320/18723 | 4.20e-03 | 2.45e-02 | 48 |
GO:00605123 | Skin | AK | prostate gland morphogenesis | 8/1910 | 27/18723 | 4.35e-03 | 2.52e-02 | 8 |
GO:00714822 | Skin | AK | cellular response to light stimulus | 22/1910 | 123/18723 | 6.33e-03 | 3.38e-02 | 22 |
GO:00466775 | Skin | AK | response to antibiotic | 11/1910 | 47/18723 | 6.62e-03 | 3.50e-02 | 11 |
GO:009719329 | Skin | cSCC | intrinsic apoptotic signaling pathway | 150/4864 | 288/18723 | 1.76e-21 | 3.34e-19 | 150 |
GO:007147824 | Skin | cSCC | cellular response to radiation | 86/4864 | 186/18723 | 1.81e-09 | 6.67e-08 | 86 |
GO:007121425 | Skin | cSCC | cellular response to abiotic stimulus | 135/4864 | 331/18723 | 2.26e-09 | 8.11e-08 | 135 |
GO:010400425 | Skin | cSCC | cellular response to environmental stimulus | 135/4864 | 331/18723 | 2.26e-09 | 8.11e-08 | 135 |
GO:004873227 | Skin | cSCC | gland development | 167/4864 | 436/18723 | 7.64e-09 | 2.44e-07 | 167 |
GO:000941114 | Skin | cSCC | response to UV | 68/4864 | 149/18723 | 1.62e-07 | 3.62e-06 | 68 |
GO:003464414 | Skin | cSCC | cellular response to UV | 46/4864 | 90/18723 | 2.95e-07 | 6.01e-06 | 46 |
GO:000931424 | Skin | cSCC | response to radiation | 166/4864 | 456/18723 | 4.37e-07 | 8.41e-06 | 166 |
GO:0008630111 | Skin | cSCC | intrinsic apoptotic signaling pathway in response to DNA damage | 46/4864 | 99/18723 | 8.60e-06 | 1.14e-04 | 46 |
GO:006145825 | Skin | cSCC | reproductive system development | 149/4864 | 427/18723 | 2.30e-05 | 2.65e-04 | 149 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CRIP1 | deletion | Frame_Shift_Del | c.121delN | p.Gly42AlafsTer? | p.G42Afs*? | P50238 | protein_coding | TCGA-KK-A5A1-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD | |||
CRIP1 | SNV | Missense_Mutation | c.193N>T | p.Gly65Cys | p.G65C | P50238 | protein_coding | deleterious(0.02) | benign(0.284) | TCGA-BR-4368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
CRIP1 | SNV | Missense_Mutation | c.182N>C | p.Phe61Ser | p.F61S | P50238 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
CRIP1 | SNV | Missense_Mutation | novel | c.143N>A | p.Gly48Asp | p.G48D | P50238 | protein_coding | deleterious(0.05) | benign(0.169) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response | |
CRIP1 | deletion | Frame_Shift_Del | c.121delN | p.Gly42AlafsTer? | p.G42Afs*? | P50238 | protein_coding | TCGA-HU-A4GU-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |